Loading
A phase 1 trial of Abenacianine run by Stephan Rogalla, terminated.
Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy is a phase 1 interventional study registered as NCT06034197 by Stephan Rogalla, with 9 participants enrolled, started 2024-02-07. Conditions recorded: Colorectal Cancer. Interventions recorded: VGT-309.
Shares Abenacianine, Vergent Bioscience and the tag pipeline.
Shares Abenacianine, Vergent Bioscience and the tag pipeline.
Shares Abenacianine, Vergent Bioscience and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/